Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report
Lin Cheng,1 Qiong Jiao,2 Yuchen Jin,1 Hao Fu,1 Huizhen Zhang,2 Libo Chen1 1Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China; 2Department of Pathology, Shanghai Jiao Tong University Affiliated Si...
Main Authors: | Cheng L, Jiao Q, Jin Y, Fu H, Zhang H, Chen L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/initial-therapy-of-advanced-anaplastic-thyroid-cancer-via-targeting-ve-peer-reviewed-article-OTT |
Similar Items
-
Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer
by: Zhijian Jin, et al.
Published: (2017-12-01) -
Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer
by: Ruiguo Zhang, et al.
Published: (2019-03-01) -
Anaplastic thyroid cancer
by: Javier Martínez Navarro, et al.
Published: (2017-10-01) -
Difficult Tracheotomy in Advanced Anaplastic Thyroid Carcinoma
by: Sedat Aydın, et al.
Published: (2019-05-01) -
Clinico-pathological profile of anaplastic thyroid carcinoma in an endemic goiter area
by: Roma Pradhan, et al.
Published: (2018-01-01)